Global Antibiotic R&D Partnership (GARDP)

💊 Cefiderocol access project: progress, challenges & the road ahead Join us for the next GARDP webinar as we discuss where we stand two years after signing the first-ever voluntary license agreement for an antibiotic. Speakers: 🔹 Monika Schneider, Ph.D., Shionogi Inc. (U.S.) 🔹 Rahul Dwivedi, GARDP 🔹 Melynda Watkins, Clinton Health Access Initiative, Inc. 🔹 Manish Dhanuka, Orchid Pharma Moderator: 🔹 Peter Beyer, Deputy Executive Director, GARDP 📅 28 March 2025 | 15:00 – 16:15 CET 📢 Register now: https://lnkd.in/dcaKx3xa #AMR #AntibioticAccess #GlobalHealth #GARDP #Webinar

What changes are needed to support the development of new treatments for multidrug-resistant infections in children? 🔍 Explore the Antimicrobial Viewpoint by Sumati Nambiar and John Bradley to learn how regulatory advancements can help. 🔗 Read more: https://lnkd.in/dM-3xBsB #AMR #AntibioticDevelopment #PediatricHealth #DrugResistance

🎉 Celebrating Women in Global Health & Antibiotic Research On this International Women’s Day, GARDP proudly celebrates the remarkable contributions of women in global health and antibiotic research. 👩🔬 Women are at the forefront of scientific innovation, driving progress in combating antibiotic resistance and developing life-saving treatments. With 70% of the global healthcare workforce made up of women, their impact is undeniable. At GARDP, we are committed to fostering an inclusive environment where women can thrive and lead. Today, we celebrate their achievements and continue to support the next generation of women leaders in antibiotic R&D.💡  #IWD2025 #WomenInScience #GenderEquality #GlobalHealth #AMR 

🆕 A New Approach to Measuring Antibiotic Resistance   A new paper introduces the Difficult-to-Treat Resistance Index, a proposed measure that considers both antibiotic resistance prevalence and local access to relevant antibiotics.    This measure aims to provide a better picture of local treatment capabilities and identify where new antibiotics are needed.   📄 Co-authored by Jennifer Cohn 🔗 Read more: https://lnkd.in/dJEkXtiq   #AMR #AntibioticAccess #DrugResistance #GlobalHealth #InfectiousDiseases

A big thank you to World Health Organization for hosting an insightful webinar on this critical report addressing antibiotic shortages in low- and middle-income countries. We’re proud to have partnered on this report and to collaborate through the SECURE initiative to expand access to antibiotics where they’re needed most. 📺 Watch the recording: https://lnkd.in/dFA8qvX8 📖 Read the report: https://lnkd.in/gDv3skMc #AntibioticAccess #GlobalHealth #AMR #SECURE

🆕 New Opportunity: Regulatory Affairs Strategy Consultant Passionate about shaping regulatory strategies for drug development? Here’s your chance to make an impact in the fight against antibiotic resistance while working with a dynamic, mission-driven team! 📄 More details in the document below. #AMR #ConsultancyOpportunity #RegulatoryAffairs

🔎 Addressing Antibiotic Shortages: Join Our Webinar! Access to antibiotics is in the spotlight! Join us on Monday 3 March for a key webinar on the SECURE initiative, co-hosted by GARDP and World Health Organization. We’ll explore the findings of a new WHO-GARDP report on tackling antibiotic shortages in low- and middle-income countries, developed in collaboration with National Ministries of Health, procurement agencies, and other key stakeholders. 📆 Monday 3 March 2025 ⏱️ 12:00-13:00 CET 📢 Don’t miss this insightful discussion—register now: https://lnkd.in/deYzNAy6 #AMR #AntibioticAccess #GlobalHealth #SECURE #GARDP

Strengthening the Antibiotic Discovery Pipeline 🧪 Earlier this month, GARDP joined C4D and H3D Foundation in Leiden for a session focused on advancing nature-inspired antibiotic drug discovery. Discussions explored future activities to strengthen the antibiotic pipeline with novel compounds, reinforcing the need for collaboration in early-stage drug discovery. #AMR #AntibioticDiscovery #Innovation #Collaboration